Filtros : "RECEPTORES" "IQ005" Limpar

Filtros



Refine with date range


  • Source: Purinergic Signalling. Unidade: IQ

    Subjects: HEPATOPATIAS, RECEPTORES, INFLAMAÇÃO, RECEPTORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ULRICH, Henning e GLASER, Talita e THOMAS, Andrew P. Purinergic signaling in liver disease: calcium signaling and induction of inflammation. Purinergic Signalling, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s11302-024-10044-9. Acesso em: 18 nov. 2024.
    • APA

      Ulrich, H., Glaser, T., & Thomas, A. P. (2024). Purinergic signaling in liver disease: calcium signaling and induction of inflammation. Purinergic Signalling. doi:10.1007/s11302-024-10044-9
    • NLM

      Ulrich H, Glaser T, Thomas AP. Purinergic signaling in liver disease: calcium signaling and induction of inflammation [Internet]. Purinergic Signalling. 2024 ;[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1007/s11302-024-10044-9
    • Vancouver

      Ulrich H, Glaser T, Thomas AP. Purinergic signaling in liver disease: calcium signaling and induction of inflammation [Internet]. Purinergic Signalling. 2024 ;[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1007/s11302-024-10044-9
  • Source: Purinergic Signalling. Unidades: ICB, IQ

    Subjects: NEUROTRANSMISSORES, RECEPTORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JUVENAL, Guilherme Araújo et al. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease. Purinergic Signalling, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s11302-024-10034-x. Acesso em: 18 nov. 2024.
    • APA

      Juvenal, G. A., Higa, G. S. V., Marques, L. B., Zampieri, T. T., Viana, F. J. C., Britto, L. R. G. de, et al. (2024). Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease. Purinergic Signalling. doi:10.1007/s11302-024-10034-x
    • NLM

      Juvenal GA, Higa GSV, Marques LB, Zampieri TT, Viana FJC, Britto LRG de, Tang Y, Illes P, Virgilio FD, Ulrich H, Pasquale R de. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease [Internet]. Purinergic Signalling. 2024 ;[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1007/s11302-024-10034-x
    • Vancouver

      Juvenal GA, Higa GSV, Marques LB, Zampieri TT, Viana FJC, Britto LRG de, Tang Y, Illes P, Virgilio FD, Ulrich H, Pasquale R de. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease [Internet]. Purinergic Signalling. 2024 ;[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1007/s11302-024-10034-x
  • Source: Neurobiology of Disease. Unidade: IQ

    Subjects: TRANSTORNOS MENTAIS, DOENÇAS NEURODEGENERATIVAS, RECEPTORES

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ILLES, Peter et al. Purinergic receptors in cognitive disturbances. Neurobiology of Disease, v. 185, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.nbd.2023.106229. Acesso em: 18 nov. 2024.
    • APA

      Illes, P., Ulrich, H., Chen, J. F., & Tang, Y. (2023). Purinergic receptors in cognitive disturbances. Neurobiology of Disease, 185, 1-16. doi:10.1016/j.nbd.2023.106229
    • NLM

      Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
    • Vancouver

      Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
  • Unidade: IQ

    Subjects: RECEPTORES, NUCLEOTÍDEOS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ULRICH, Henning e ILLES, Peter e GLASER, Talita. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. . Cham: Springer. . Acesso em: 18 nov. 2024. , 2023
    • APA

      Ulrich, H., Illes, P., & Glaser, T. (2023). Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. Cham: Springer.
    • NLM

      Ulrich H, Illes P, Glaser T. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. 2023 ;[citado 2024 nov. 18 ]
    • Vancouver

      Ulrich H, Illes P, Glaser T. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. 2023 ;[citado 2024 nov. 18 ]
  • Source: Livro de Resumos. Conference titles: Annual Meeting of the Brazilian Society for Biochemistry and Molecular Biology/SBBq. Unidades: FCFRP, IQ

    Subjects: RECEPTORES, DOR

    PrivadoAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROLDÃO, Allan Pradelli et al. Structural characterization of the PLCγ SH2 domains binding to growth factor receptor coupled kinases. 2023, Anais.. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular, 2023. Disponível em: https://www2.sbbq.org.br/reuniao/images/livro_completo2023. Acesso em: 18 nov. 2024.
    • APA

      Roldão, A. P., Souza, N. J. de, Biazotti, V. P., Batista, F. A. H., Sgro, G. G., Figueira, A. C. M., & Schechtman, D. (2023). Structural characterization of the PLCγ SH2 domains binding to growth factor receptor coupled kinases. In Livro de Resumos. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular. Recuperado de https://www2.sbbq.org.br/reuniao/images/livro_completo2023
    • NLM

      Roldão AP, Souza NJ de, Biazotti VP, Batista FAH, Sgro GG, Figueira ACM, Schechtman D. Structural characterization of the PLCγ SH2 domains binding to growth factor receptor coupled kinases [Internet]. Livro de Resumos. 2023 ;[citado 2024 nov. 18 ] Available from: https://www2.sbbq.org.br/reuniao/images/livro_completo2023
    • Vancouver

      Roldão AP, Souza NJ de, Biazotti VP, Batista FAH, Sgro GG, Figueira ACM, Schechtman D. Structural characterization of the PLCγ SH2 domains binding to growth factor receptor coupled kinases [Internet]. Livro de Resumos. 2023 ;[citado 2024 nov. 18 ] Available from: https://www2.sbbq.org.br/reuniao/images/livro_completo2023
  • Source: Trends in Pharmacological Sciences. Unidade: IQ

    Subjects: NEURÔNIOS, OLFATO, RECEPTORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      NARESSI, Raquel Gonçalves e SCHECHTMAN, Deborah e MALNIC, Bettina. Odorant receptors as potential drug targets. Trends in Pharmacological Sciences, v. 44, n. 1, p. 11-14, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.tips.2022.08.003. Acesso em: 18 nov. 2024.
    • APA

      Naressi, R. G., Schechtman, D., & Malnic, B. (2023). Odorant receptors as potential drug targets. Trends in Pharmacological Sciences, 44( 1), 11-14. doi:10.1016/j.tips.2022.08.003
    • NLM

      Naressi RG, Schechtman D, Malnic B. Odorant receptors as potential drug targets [Internet]. Trends in Pharmacological Sciences. 2023 ; 44( 1): 11-14.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.tips.2022.08.003
    • Vancouver

      Naressi RG, Schechtman D, Malnic B. Odorant receptors as potential drug targets [Internet]. Trends in Pharmacological Sciences. 2023 ; 44( 1): 11-14.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.tips.2022.08.003
  • Source: Parasitology Research. Unidade: IQ

    Subjects: TOXOPLASMOSE CONGÊNITA, SISTEMA NERVOSO CENTRAL, RECEPTORES, POLIFENÓIS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BISSACOTTI, Bianca Fagan et al. Curcumin modulates neurogliogenesis and purinergic receptor expression in neural precursor cells infected with Toxoplasma gondii. Parasitology Research, v. 122, n. 1, p. 77-84, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00436-022-07698-y. Acesso em: 18 nov. 2024.
    • APA

      Bissacotti, B. F., Copetti, P. M., Bottari, N. B., Palma, T. V., Pillat, M. M., Andrade, C. M. de, et al. (2023). Curcumin modulates neurogliogenesis and purinergic receptor expression in neural precursor cells infected with Toxoplasma gondii. Parasitology Research, 122( 1), 77-84. doi:10.1007/s00436-022-07698-y
    • NLM

      Bissacotti BF, Copetti PM, Bottari NB, Palma TV, Pillat MM, Andrade CM de, Morsch VMM, Ulrich H, Silva AS da. Curcumin modulates neurogliogenesis and purinergic receptor expression in neural precursor cells infected with Toxoplasma gondii [Internet]. Parasitology Research. 2023 ; 122( 1): 77-84.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00436-022-07698-y
    • Vancouver

      Bissacotti BF, Copetti PM, Bottari NB, Palma TV, Pillat MM, Andrade CM de, Morsch VMM, Ulrich H, Silva AS da. Curcumin modulates neurogliogenesis and purinergic receptor expression in neural precursor cells infected with Toxoplasma gondii [Internet]. Parasitology Research. 2023 ; 122( 1): 77-84.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00436-022-07698-y
  • Source: Frontiers in Oncology. Unidade: IQ

    Subjects: RECEPTORES, NEUROBLASTOMA, RESISTÊNCIA MICROBIANA ÀS DROGAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SAMPAIO, Vanessa Fernandes Arnaud et al. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma. Frontiers in Oncology, v. 12, p. 1-19 art. 966404, 2022Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.966404. Acesso em: 18 nov. 2024.
    • APA

      Sampaio, V. F. A., Bento, C. A., Glaser, T., Adinolfi, E., Ulrich, H., & Lameu, C. (2022). P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma. Frontiers in Oncology, 12, 1-19 art. 966404. doi:10.3389/fonc.2022.966404
    • NLM

      Sampaio VFA, Bento CA, Glaser T, Adinolfi E, Ulrich H, Lameu C. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma [Internet]. Frontiers in Oncology. 2022 ; 12 1-19 art. 966404.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fonc.2022.966404
    • Vancouver

      Sampaio VFA, Bento CA, Glaser T, Adinolfi E, Ulrich H, Lameu C. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma [Internet]. Frontiers in Oncology. 2022 ; 12 1-19 art. 966404.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fonc.2022.966404
  • Source: International Journal of Molecular Sciences. Unidade: IQ

    Subjects: SISTEMA NERVOSO CENTRAL, COLESTEROL, RECEPTORES

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PASSARELLA, Daniela et al. Bidirectional Control between cholesterol shuttle and purine signal at the central nervous system. International Journal of Molecular Sciences, v. 23, p. 1-20 art. 8683, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms23158683. Acesso em: 18 nov. 2024.
    • APA

      Passarella, D., Ronci, M., Di Liberto, V., Zuccarini, M., Mudò, G., Porcile, C., et al. (2022). Bidirectional Control between cholesterol shuttle and purine signal at the central nervous system. International Journal of Molecular Sciences, 23, 1-20 art. 8683. doi:10.3390/ijms23158683
    • NLM

      Passarella D, Ronci M, Di Liberto V, Zuccarini M, Mudò G, Porcile C, Frinchi M, Di Iorio P, Ulrich H, Russo C. Bidirectional Control between cholesterol shuttle and purine signal at the central nervous system [Internet]. International Journal of Molecular Sciences. 2022 ; 23 1-20 art. 8683.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/ijms23158683
    • Vancouver

      Passarella D, Ronci M, Di Liberto V, Zuccarini M, Mudò G, Porcile C, Frinchi M, Di Iorio P, Ulrich H, Russo C. Bidirectional Control between cholesterol shuttle and purine signal at the central nervous system [Internet]. International Journal of Molecular Sciences. 2022 ; 23 1-20 art. 8683.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/ijms23158683
  • Source: Ecotoxicology and Environmental Contamination. Unidade: IQ

    Subjects: RECEPTORES, TRANSCRIÇÃO GÊNICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAMPOS, Marcelo et al. Purinergic receptor antagonist A438079 disrupts benzo[a] pyrene-Mediated IL-1β, CYP1A and CYP1B transcript induction pathway in zebrafish: insights into possible mechanisms. Ecotoxicology and Environmental Contamination, v. 17, n. 2, p. 78-84, 2022Tradução . . Disponível em: https://dx.doi.org/10.5132/eec.2022.02.09. Acesso em: 18 nov. 2024.
    • APA

      Campos, M., Lameu, C., Chamelete, A., Lima, A. V. B., Cândido, N., Rahal, P., et al. (2022). Purinergic receptor antagonist A438079 disrupts benzo[a] pyrene-Mediated IL-1β, CYP1A and CYP1B transcript induction pathway in zebrafish: insights into possible mechanisms. Ecotoxicology and Environmental Contamination, 17( 2), 78-84. doi:10.5132/eec.2022.02.09
    • NLM

      Campos M, Lameu C, Chamelete A, Lima AVB, Cândido N, Rahal P, Ulrich H, Almeida EA de. Purinergic receptor antagonist A438079 disrupts benzo[a] pyrene-Mediated IL-1β, CYP1A and CYP1B transcript induction pathway in zebrafish: insights into possible mechanisms [Internet]. Ecotoxicology and Environmental Contamination. 2022 ; 17( 2): 78-84.[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.5132/eec.2022.02.09
    • Vancouver

      Campos M, Lameu C, Chamelete A, Lima AVB, Cândido N, Rahal P, Ulrich H, Almeida EA de. Purinergic receptor antagonist A438079 disrupts benzo[a] pyrene-Mediated IL-1β, CYP1A and CYP1B transcript induction pathway in zebrafish: insights into possible mechanisms [Internet]. Ecotoxicology and Environmental Contamination. 2022 ; 17( 2): 78-84.[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.5132/eec.2022.02.09
  • Source: Frontiers Immunology. Unidade: IQ

    Subjects: ESCLEROSE MÚLTIPLA, ADENOSINA, RECEPTORES

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Eduardo Duarte et al. The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis. Frontiers Immunology, v. 13, p. 1-10 art. 946698, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.946698. Acesso em: 18 nov. 2024.
    • APA

      Silva, E. D., Ulrich, H., Giacomelli, Á. O., Hartung, H. P., Meuth, S. G., & Peixoto, C. A. (2022). The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis. Frontiers Immunology, 13, 1-10 art. 946698. doi:10.3389/fimmu.2022.946698
    • NLM

      Silva ED, Ulrich H, Giacomelli ÁO, Hartung HP, Meuth SG, Peixoto CA. The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis [Internet]. Frontiers Immunology. 2022 ; 13 1-10 art. 946698.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fimmu.2022.946698
    • Vancouver

      Silva ED, Ulrich H, Giacomelli ÁO, Hartung HP, Meuth SG, Peixoto CA. The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis [Internet]. Frontiers Immunology. 2022 ; 13 1-10 art. 946698.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fimmu.2022.946698
  • Source: Frontiers in Cellular Neuroscience. Unidade: IQ

    Subjects: GENOMAS, RECEPTORES, EPIGÊNESE GENÉTICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Artur Guazzelli Leme et al. Genetic background effects on the expression of an odorant receptor gene. Frontiers in Cellular Neuroscience, v. 15, p. 1-13 art. 646413, 2021Tradução . . Disponível em: https://doi.org/10.3389/fncel.2021.646413. Acesso em: 18 nov. 2024.
    • APA

      Silva, A. G. L., Nagai, M. H., Nakahara, T. S., & Malnic, B. (2021). Genetic background effects on the expression of an odorant receptor gene. Frontiers in Cellular Neuroscience, 15, 1-13 art. 646413. doi:10.3389/fncel.2021.646413
    • NLM

      Silva AGL, Nagai MH, Nakahara TS, Malnic B. Genetic background effects on the expression of an odorant receptor gene [Internet]. Frontiers in Cellular Neuroscience. 2021 ; 15 1-13 art. 646413.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fncel.2021.646413
    • Vancouver

      Silva AGL, Nagai MH, Nakahara TS, Malnic B. Genetic background effects on the expression of an odorant receptor gene [Internet]. Frontiers in Cellular Neuroscience. 2021 ; 15 1-13 art. 646413.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fncel.2021.646413
  • Source: Jornal da USP. Unidade: IQ

    Subjects: CORONAVIRUS, COVID-19, CÉREBRO, SISTEMA NERVOSO CENTRAL, RECEPTORES

    Versão PublicadaAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ULRICH, Henning e RIBEIRO, Deidiane Elisa e GIACOMELLI, Ágatha Oliveira. Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires]. Jornal da USP. São Paulo: Instituto de Química, Universidade de São Paulo. Disponível em: https://jornal.usp.br/ciencias/coronavirus-no-cerebro-drogas-que-bloqueiam-receptor-poderiam-prevenir-ou-tratar-problemas-neurologicos. Acesso em: 18 nov. 2024. , 2021
    • APA

      Ulrich, H., Ribeiro, D. E., & Giacomelli, Á. O. (2021). Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires]. Jornal da USP. São Paulo: Instituto de Química, Universidade de São Paulo. Recuperado de https://jornal.usp.br/ciencias/coronavirus-no-cerebro-drogas-que-bloqueiam-receptor-poderiam-prevenir-ou-tratar-problemas-neurologicos
    • NLM

      Ulrich H, Ribeiro DE, Giacomelli ÁO. Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires] [Internet]. Jornal da USP. 2021 ;[citado 2024 nov. 18 ] Available from: https://jornal.usp.br/ciencias/coronavirus-no-cerebro-drogas-que-bloqueiam-receptor-poderiam-prevenir-ou-tratar-problemas-neurologicos
    • Vancouver

      Ulrich H, Ribeiro DE, Giacomelli ÁO. Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires] [Internet]. Jornal da USP. 2021 ;[citado 2024 nov. 18 ] Available from: https://jornal.usp.br/ciencias/coronavirus-no-cerebro-drogas-que-bloqueiam-receptor-poderiam-prevenir-ou-tratar-problemas-neurologicos
  • Source: European Journal of Pharmacology. Unidade: IQ

    Subjects: NEOPLASIAS ESOFÁGICAS, NUCLEOTÍDEOS, PROLIFERAÇÃO CELULAR, RECEPTORES

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ZAPARTE, Aline et al. P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway. European Journal of Pharmacology, v. 891, p. 1-12 art. 173687, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2020.173687. Acesso em: 18 nov. 2024.
    • APA

      Zaparte, A., Cappellari, A. R., Brandão, C. A., Souza, J. B. de, Borges, T. J., Kist, L. W., et al. (2021). P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway. European Journal of Pharmacology, 891, 1-12 art. 173687. doi:10.1016/j.ejphar.2020.173687
    • NLM

      Zaparte A, Cappellari AR, Brandão CA, Souza JB de, Borges TJ, Kist LW, Bogo MR, Zerbini LF, Pinto LFR, Glaser T, Gonçalves MCB, Naaldijk Y, Ulrich H, Morrone FB. P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway [Internet]. European Journal of Pharmacology. 2021 ; 891 1-12 art. 173687.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173687
    • Vancouver

      Zaparte A, Cappellari AR, Brandão CA, Souza JB de, Borges TJ, Kist LW, Bogo MR, Zerbini LF, Pinto LFR, Glaser T, Gonçalves MCB, Naaldijk Y, Ulrich H, Morrone FB. P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway [Internet]. European Journal of Pharmacology. 2021 ; 891 1-12 art. 173687.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173687
  • Source: Cytometry. Unidade: IQ

    Subjects: CÉLULAS-TRONCO, NEOPLASIAS CEREBRAIS, CITOMETRIA DE FLUXO, RECEPTORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PILLAT, Micheli Mainardi et al. Mesenchymal stem cell-glioblastoma interactions mediated via kinin receptors unveiled by cytometry. Cytometry, v. 99, p. 152–163, 2021Tradução . . Disponível em: https://doi.org/10.1002/cyto.a.24299. Acesso em: 18 nov. 2024.
    • APA

      Pillat, M. M., Giacomelli, A. O., Oliveira, M. das N., Andrejew, R., Turrini, N., Baranova, J., et al. (2021). Mesenchymal stem cell-glioblastoma interactions mediated via kinin receptors unveiled by cytometry. Cytometry, 99, 152–163. doi:10.1002/cyto.a.24299
    • NLM

      Pillat MM, Giacomelli AO, Oliveira M das N, Andrejew R, Turrini N, Baranova J, Turnšek TL, Ulrich H. Mesenchymal stem cell-glioblastoma interactions mediated via kinin receptors unveiled by cytometry [Internet]. Cytometry. 2021 ; 99 152–163.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/cyto.a.24299
    • Vancouver

      Pillat MM, Giacomelli AO, Oliveira M das N, Andrejew R, Turrini N, Baranova J, Turnšek TL, Ulrich H. Mesenchymal stem cell-glioblastoma interactions mediated via kinin receptors unveiled by cytometry [Internet]. Cytometry. 2021 ; 99 152–163.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/cyto.a.24299
  • Source: Stem Cell Reviews and Reports. Unidade: IQ

    Subjects: RECEPTORES, COVID-19, QUIMIOTAXIA, CÉLULAS-TRONCO, NEUTRÓFILOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PETIZ, Lyvia Lintzmaier et al. P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation. Stem Cell Reviews and Reports, v. 17, p. 241–252, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12015-021-10129-7. Acesso em: 18 nov. 2024.
    • APA

      Petiz, L. L., Glaser, T., Scharfstein, J., Ratajczak, M. Z., & Ulrich, H. (2021). P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation. Stem Cell Reviews and Reports, 17, 241–252. doi:10.1007/s12015-021-10129-7
    • NLM

      Petiz LL, Glaser T, Scharfstein J, Ratajczak MZ, Ulrich H. P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation [Internet]. Stem Cell Reviews and Reports. 2021 ; 17 241–252.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12015-021-10129-7
    • Vancouver

      Petiz LL, Glaser T, Scharfstein J, Ratajczak MZ, Ulrich H. P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation [Internet]. Stem Cell Reviews and Reports. 2021 ; 17 241–252.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12015-021-10129-7
  • Source: Cell and Tissue Research. Unidade: IQ

    Subjects: EPITÉLIO, MAMÍFEROS, OLFATO, RECEPTORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KURIAN, Smija M et al. Odor coding in the mammalian olfactory epithelium. Cell and Tissue Research, v. 383, p. 445–456, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00441-020-03327-1. Acesso em: 18 nov. 2024.
    • APA

      Kurian, S. M., Naressi, R. G., Manoel, D., Barwich, A. -S., Malnic, B., & Saraiva, L. R. (2021). Odor coding in the mammalian olfactory epithelium. Cell and Tissue Research, 383, 445–456. doi:10.1007/s00441-020-03327-1
    • NLM

      Kurian SM, Naressi RG, Manoel D, Barwich A-S, Malnic B, Saraiva LR. Odor coding in the mammalian olfactory epithelium [Internet]. Cell and Tissue Research. 2021 ; 383 445–456.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00441-020-03327-1
    • Vancouver

      Kurian SM, Naressi RG, Manoel D, Barwich A-S, Malnic B, Saraiva LR. Odor coding in the mammalian olfactory epithelium [Internet]. Cell and Tissue Research. 2021 ; 383 445–456.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00441-020-03327-1
  • Source: Frontiers in Pharmacology. Unidade: IQ

    Subjects: PURINAS, RECEPTORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CIRUELA, Francisco et al. Purinergic Signaling 2020: the state-of-the-art commented by the members of the Italian Purine Club [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fphar.2021.768923. Acesso em: 18 nov. 2024. , 2021
    • APA

      Ciruela, F., Fuxe, K., Illes, P., Ulrich, H., & Caciagli, F. (2021). Purinergic Signaling 2020: the state-of-the-art commented by the members of the Italian Purine Club [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2021.768923
    • NLM

      Ciruela F, Fuxe K, Illes P, Ulrich H, Caciagli F. Purinergic Signaling 2020: the state-of-the-art commented by the members of the Italian Purine Club [Editorial] [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-3.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fphar.2021.768923
    • Vancouver

      Ciruela F, Fuxe K, Illes P, Ulrich H, Caciagli F. Purinergic Signaling 2020: the state-of-the-art commented by the members of the Italian Purine Club [Editorial] [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-3.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fphar.2021.768923
  • Source: Frontiers in Pharmacology. Unidade: IQ

    Subjects: DOENÇAS NEURODEGENERATIVAS, RECEPTORES, ANTAGONISTAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GLASER, Talita et al. Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases. Frontiers in Pharmacology, v. 12, p. 1-7 art. 659097, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.659097. Acesso em: 18 nov. 2024.
    • APA

      Glaser, T., Giacomelli, Á. O., Petiz, L. L., Ribeiro, D. E., Andrejew, R., & Ulrich, H. (2021). Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases. Frontiers in Pharmacology, 12, 1-7 art. 659097. doi:10.3389/fphar.2021.659097
    • NLM

      Glaser T, Giacomelli ÁO, Petiz LL, Ribeiro DE, Andrejew R, Ulrich H. Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-7 art. 659097.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fphar.2021.659097
    • Vancouver

      Glaser T, Giacomelli ÁO, Petiz LL, Ribeiro DE, Andrejew R, Ulrich H. Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-7 art. 659097.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fphar.2021.659097
  • Source: Neuroscience Bulletin. Unidade: IQ

    Subjects: AÇÚCAR, CÉREBRO, RECEPTORES

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAO, Xin et al. A Neural circuit for gut-induced sugar preference. Neuroscience Bulletin, v. 37, n. 5 p. 754–756, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12264-021-00692-x. Acesso em: 18 nov. 2024.
    • APA

      Cao, X., Yin, H. -Y., Ulrich, H., Semyanov, A., & Tang, Y. (2021). A Neural circuit for gut-induced sugar preference. Neuroscience Bulletin, 37( 5 p. 754–756). doi:10.1007/s12264-021-00692-x
    • NLM

      Cao X, Yin H-Y, Ulrich H, Semyanov A, Tang Y. A Neural circuit for gut-induced sugar preference [Internet]. Neuroscience Bulletin. 2021 ; 37( 5 p. 754–756):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12264-021-00692-x
    • Vancouver

      Cao X, Yin H-Y, Ulrich H, Semyanov A, Tang Y. A Neural circuit for gut-induced sugar preference [Internet]. Neuroscience Bulletin. 2021 ; 37( 5 p. 754–756):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12264-021-00692-x

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024